{"id":436,"date":"2026-01-25T07:05:29","date_gmt":"2026-01-25T07:05:29","guid":{"rendered":"https:\/\/cninmed.com\/en\/?p=436"},"modified":"2026-01-25T07:11:55","modified_gmt":"2026-01-25T07:11:55","slug":"china-bd-2026","status":"publish","type":"post","link":"https:\/\/cninmed.com\/en\/2026\/436.html","title":{"rendered":"[China BD 2026]"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Announced Date: 2025-12-15 (December 15, 2025)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Licensor (Seller): Innolake Biopharm  (Innolake, \u56e0\u8bfa\u6e56)  (China)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Licensee (Buyer): \u00a0Ellipses Pharma (UK)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Asset Name: ILB-3101 (EP0028)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Asset Modality: ADC;  Asset Target: B7H3<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Potential Indication: Graves\u2019 Disease and Thyroid Eye Disease<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Current Stage:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Scope of Authority:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Agreement grants Yarrow Bioscience, Inc. exclusive global ex-China rights to develop and commercialize GS-098 (YB-101) for Graves\u2019 disease (GD) and thyroid eye disease (TED).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Payment Detail:  Undisclosed.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Link:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Note:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Announced Date: 2025-12-15 (December 15, 2025) Licensor (Seller): Innolake Biopharm (Innolake, \u56e0\u8bfa\u6e56) (China) Licensee (Buyer): \u00a0Ellipses &hellip; <a title=\"[China BD 2026]\" class=\"hm-read-more\" href=\"https:\/\/cninmed.com\/en\/2026\/436.html\"><span class=\"screen-reader-text\">[China BD 2026]<\/span>Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-436","post","type-post","status-publish","format-standard","hentry","category-china-license-out"],"_links":{"self":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/436","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/comments?post=436"}],"version-history":[{"count":4,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/436\/revisions"}],"predecessor-version":[{"id":441,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/436\/revisions\/441"}],"wp:attachment":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/media?parent=436"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/categories?post=436"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/tags?post=436"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}